The ratio of a urinary tobacco-specific lung carcinogen metabolite to cotinine is significantly higher in passive than in active smokers

Effect of Oral Snus and Medicinal Nicotine in Smokers on Toxicant Exposure and Withdrawal Symptoms: A Feasibility Study

(2011) M. Kotlyar et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Metabolites of a Tobacco-Specific Lung Carcinogen in Children Exposed to Secondhand or Thirdhand Tobacco Smoke in Their Homes

(2011) J. L. Thomas et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Comparison of Urine Cotinine and the Tobacco-Specific Nitrosamine Metabolite 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol (NNAL) and Their Ratio to Discriminate Active From Passive Smoking

(2011) Maciej Lukasz Goniewicz et al.   NICOTINE & TOBACCO RESEARCH

Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation

(2010) Dorothy K. Hatsukami et al.   ADDICTION

Temporal stability of urinary and plasma biomarkers of tobacco smoke exposure among cigarette smokers

(2010) Timothy R. Church et al.   BIOMARKERS

Urine Cotinine Underestimates Exposure to the Tobacco-Derived Lung Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone in Passive Compared with Active Smokers

(2010) N. Benowitz et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Urine Concentrations of a Tobacco-Specific Nitrosamine Carcinogen in the U.S. Population from Secondhand Smoke Exposure

(2010) J. T. Bernert et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

UGT2B10 Genotype Influences Nicotine Glucuronidation, Oxidation, and Consumption

(2010) J. Z. Berg et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Tobacco Smoke Exposure in Nonsmoking Hospitality Workers before and after a State Smoking Ban

(2010) J. A. Jensen et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Formation of carcinogens indoors by surface-mediated reactions of nicotine with nitrous acid, leading to potential thirdhand smoke hazards

(2010) M. Sleiman et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Elimination Kinetics of the Tobacco-Specific Biomarker and Lung Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol

(2009) M. L. Goniewicz et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Nicotine Metabolism in African Americans and European Americans: Variation in Glucuronidation by Ethnicity and UGT2B10 Haplotype

(2009) J. Z. Berg et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Extensive Metabolic Activation of the Tobacco-Specific Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone in Smokers

(2008) I. Stepanov et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Smokers with the CHRNA Lung Cancer-Associated Variants Are Exposed to Higher Levels of Nicotine Equivalents and a Carcinogenic Tobacco-Specific Nitrosamine

(2008) L. Le Marchand et al.   CANCER RESEARCH

Smoking reduction fails to improve clinical and biological markers of cardiac disease: A randomized controlled trial

(2008) Anne Joseph et al.   NICOTINE & TOBACCO RESEARCH

Progress and Challenges in Selected Areas of Tobacco Carcinogenesis

(2007) Stephen S. Hecht   CHEMICAL RESEARCH IN TOXICOLOGY